Effects of isometric contraction on intramuscular level of neuropeptide Y and local pain perception

References

• Veiersted KB, Westgaard RH. Development of trapezius myalgia among female workers performing light manual work. Scand J Work Environ Health 1993; 19: 277–83
   PubMed Web of Science ®Google Scholar
• Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic subgroups of painful temporomandibular disorders (TMD). J Dent Res 2002; 81: 284–8
   PubMed Web of Science ®Google Scholar
• Lindman R, Hagberg M, Angqvist KA, Soderlund K, Hultman E, Thornell LE. Changes in muscle morphology in chronic trapezius myalgia. Scand J Work Environ Health 1991; 17: 347–55
   PubMed Web of Science ®Google Scholar
• Hedenberg-Magnusson B, Ernberg M, Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibromyalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol Scand 1997; 55: 344–9
   PubMed Web of Science ®Google Scholar
• Larsson S-E, Ålund M, Cai H, Öberg P-Å. Chronic pain after soft tissue injury of the cervical spine: trapezius muscle blood flow and electromyography at static loads and fatigue. Pain 1994; 57: 173–80
   PubMed Web of Science ®Google Scholar
• Larsson R, Öberg PA, Larsson SE. Changes of trapezius muscle blood flow and electromyography in chronic neck pain due to trapezius myalgia. Pain 1999; 79: 45–50
   PubMed Web of Science ®Google Scholar
• Rosendal L, Larsson B, Kristiansen J, Peolsson M, Sogaard K, Kjaer M, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain 2004; 112: 324–34
   PubMed Web of Science ®Google Scholar
• Henriksson KG, Bengtsson A. Fibromyalgia – a clinical entity?. Scand J Physiol Pharmacol 1991; 69: 672–7
   PubMed Web of Science ®Google Scholar
• Mense S. Nociception from skeletal muscle in relation to clinical muscle pain (Review). Pain 1993; 54: 241–89
   PubMed Web of Science ®Google Scholar
• Levine JD, Coderre TJ, Basbaum AI. The peripheral nervous system and the inflammatory process. Proceedings of the Vth World Congress on Pain, R Dubner, GF Gebhard, MR Bond. Elsevier, Amsterdam 1988; 33–43
   Google Scholar
• Graven-Nielsen T, Mense S. The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain 2001; 17: 2–10
   PubMed Web of Science ®Google Scholar
• Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. The level of serotonin in the superficial muscle in relation to local pain and allodynia. Life Sci 1999; 65: 313–25
   PubMed Web of Science ®Google Scholar
• Hedenberg-Magnusson B, Alstergren P, Ernberg M, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand 2001; 59: 348–55
   PubMed Web of Science ®Google Scholar
• Lundberg JM, Terenius L, Hökfelt T, Martling C-R, Tatemoto K, Mutt V, et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116: 477–80
   PubMedGoogle Scholar
• Zhang X, Meister B, Elde R, Verge VM, Hokfeldt T. Large calibre primary afferent neurons projecting to the gracile nucleus express neuropeptide Y after sciatic nerve lesions: an immunohistochemical and in situ hybridization study in rats. Eur J Neurosci 1993; 5: 1510–19
   PubMed Web of Science ®Google Scholar
• Ma W, Bisby MA. Ultrastructural localization of increased neuropeptide immunoreactivity in the axons and cells of the gracile nucleus following chronic constriction injury of the sciatic nerve. Neuroscience 1999; 93: 335–48
   PubMedGoogle Scholar
• Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci 1995; 771: 219–33
   PubMed Web of Science ®Google Scholar
• Lundberg JM, Martinsson A, Hemsen A, Theodorsson-Norheim E, Svedenhag J, Ekblom B, et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun 1985; 133: 30–6
   PubMed Web of Science ®Google Scholar
• Morris MJ, Cox HS, Lambert GW, Kaye DM, Jennings GL, Meredith IT, et al. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Hypertension 1997; 29: 137–43
   PubMed Web of Science ®Google Scholar
• Zukowska Z, Grant DS, Lee EW. Neuropeptide Y. A novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 2003; 13: 86–92
   PubMed Web of Science ®Google Scholar
• Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003; 111: 1853–62
   PubMedGoogle Scholar
• Anderberg UM, Zhurong L, Berglund L, Nyberg F. Elevated plasma levels of neuropeptide Y in female fibromyalgia patients. Eur J Pain 1999; 3: 19–30
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–92
   PubMed Web of Science ®Google Scholar
• Ashina M, Bendtsen L, Jensen R, Ekman R, Olesen J. Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache. Pain 1999; 83: 541–7
   PubMedGoogle Scholar
• Onuoha GN, Alpar EK. Calcitonin gene-related peptide and other neuropeptides in the plasma of patients with soft tissue injury. Life Sci 1999; 65: 1351–8
   PubMed Web of Science ®Google Scholar
• Lee EW, Grant DS, Movafagh S, Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 2003; 24: 99–106
   PubMed Web of Science ®Google Scholar
• Grönlund B, Astrup A, Bie P, Christensen NJ. Noradrenaline release in skeletal muscle and in adipose tissue studied by microdialysis. Clin Sci 1991; 80: 595–8
   Google Scholar
• Baron R, Levine JD, Fields HL. Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain?. Muscle Nerve 1999; 22: 678–95
   PubMed Web of Science ®Google Scholar
• Wahren LK, Gordh T, Torebjork E. Effects of regional intravenous guanethidin in patients with neuralgia in the hand; a follow-up study over a decade. Pain 1995; 62: 379–85
   PubMed Web of Science ®Google Scholar
• Mense S. Slowly conducting afferent fibres from deep tissues: neurobiological properties and central nervous actions. Prog Sens Physiol 1986; 6: 139–219
   Google Scholar
• Elam M, Olausson B, Skarphedinsson JO, Wallin BG. Does sypathetic nerve discharge affect the firing of polymodal C-fibre afferents in humans?. Brain 1999; 122: 2237–44
   PubMedGoogle Scholar
• Bjerring P, Arent-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 1990; 64: 173–7
   PubMed Web of Science ®Google Scholar
• Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J. The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. Acta Physiol Scand 1992; 146: 87–97
   PubMedGoogle Scholar
• Mertes PM, Beck B, Jaboin Y, Stricker A, Carteaux JP, Pinelli G, et al. Microdialysis in the estimation of interstitial myocardial neuropeptide Y release. Regul Pept 1993; 49: 81–90
   PubMedGoogle Scholar
• Theodorsson-Norheim E, Hemsen A, Brodin E, Lundberg JM. Radioimmunassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest 1985; 45: 355–65
   PubMed Web of Science ®Google Scholar
• Schüldt K, Harms-Ringdahl B. Activity levels during isometric test contractions of neck and shoulder muscles. Scand J Rehab Med 1988; 20: 117–27
   PubMedGoogle Scholar
• Theodorsson-Norheim E, Hemsen A, Brodin E, Lundberg JM. Sample handling techniques when analyzing regulatory peptides. Life Sci 1987; 41: 845–8
   PubMed Web of Science ®Google Scholar
• Hoffmann KD, Matthews MA. Comparison of sympathetic neurons in orofacial and upper extremity nerves: implications for causalgia. J Oral Maxillofac Surg 1990; 48: 720–6
   PubMedGoogle Scholar
• Buckwalter JB, Hamann JJ, Kluess HA, Clifford PS. Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y?. Am J Physiol Heart Circ Physiol 2004 Jul; 287(1)H144–9
   PubMedGoogle Scholar
• Eriksson PO, Thornell LE. Histochemical and morphological muscle-fibre characteristics of the human masseter, the medial pterygoid and the temporal muscles. Arch Oral Biol 1983; 28: 781–95
   PubMed Web of Science ®Google Scholar
• Stål P. Characterization of human orofacial and masticatory muscles with respect to fibre types, myosins and capillaries. Morphological, enzyme-histochemical, immuno-histochemical and biochemical investigations. Swed Dent J Suppl 1994; 98: 1–55
   PubMedGoogle Scholar
• Svensson P, Arendt-Nielsen L. Effects of 5 days of repeated submaximal clenching on masticatory muscle pain and tenderness: an experimental study. J Orofac Pain 1996; 10: 330–8
   PubMedGoogle Scholar
• Babenko V, Graven-Nielsen T, Svensson P, Drewes AM, Jensen TS, Arendt-Nielsen L. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain 1999; 82: 1–8
   PubMed Web of Science ®Google Scholar
• Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 2000; 85: 31–9
   PubMed Web of Science ®Google Scholar
• Svensson P, Cairns BE, Wang K, Hu JW, Graven-Nielsen T, Arendt-Nielsen L, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003; 101: 221–7
   PubMedGoogle Scholar
• Dao TT, LeResche L. Gender differences in pain. J Orofac Pain 2000;14:169–84; discussion 184–95.
   PubMed Web of Science ®Google Scholar
• Ashina M, Jorgensen M, Stallknecht B, Mork H, Bendtsen L, Pedersen JF, et al. No release of interstitial glutamate in experimental human model of muscle pain. Eur J Pain 2005; 9: 337–43
   PubMedGoogle Scholar
• O'Connor PJ, Cook DB. Moderate-intensity muscle pain can be produced and sustained during cycle ergometry. Med Sci Sporst Exerc 2001; 33: 1046–51
   PubMedGoogle Scholar